Taiwan FDA registration 11c1945c49d777ca81fa9288b2d7b735

Cimosir protein S reagent

TW: 希摩西爾蛋白S試劑
Taiwan flagTaiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.·Registered Jan 18, 2013 – Jan 18, 2028Active
Registration details
Analysis ID
11c1945c49d777ca81fa9288b2d7b735
Customs Code
DHA00602432000
Company information
Manufacturer Country
United States
Authorized Representative
Werfen Taiwan Limited
Product details
Intended Use
The concentration of protein S in human citrate acidated plasma was determined in the IL automatic coagulation instrument system (ACL TOP Family, ACL ELITE/ELITE PRO/8/9/1000, ACL Advance and ACL classic (100-7000)).
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.7290 factor deficiency test
Import Information
import
Dates and status
Registration Date
Jan 18, 2013
Expiry Date
Jan 18, 2028
Companies making similar products

Top companies providing products similar to "Cimosir protein S reagent"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Cimosir protein S reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 11c1945c49d777ca81fa9288b2d7b735 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including INSTRUMENTATION LABORATORY CO., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations